| Literature DB >> 32098897 |
Tomonori Kimura1, Takuro Okamura1, Keiko Iwai1, Yoshitaka Hashimoto1, Takafumi Senmaru1, Emi Ushigome1, Masahide Hamaguchi1, Mai Asano1, Masahiro Yamazaki1, Michiaki Fukui2.
Abstract
OBJECTIVE: Reduction of muscle mass and strength is an important treatment target for patients with type 2 diabetes. Recent studies have reported that high-intensity resistance training improves physical function; however, all patients found it difficult to perform high-intensity resistance training. Radio calisthenics, considered as therapeutic exercises to promote health in Japan, are simple exercises that can be performed regardless of age and help move the muscles and joints of the whole body effectively according to the rhythm of radio. We investigated the efficacy of radio calisthenics for muscle mass in patients with type 2 diabetes in this retrospective cohort study. RESEARCH DESIGN AND METHODS: A total of 42 hospitalized patients with type 2 diabetes were recruited. The skeletal muscle mass index (SMI, kg/m2) was calculated as appendicular muscle mass (kg) divided by height squared (m2). We defined the change of SMI as the difference of SMI between the beginning and end of hospitalization.Entities:
Keywords: exercise; muscle mass; radio calisthenics; sarcopenia; type 2 diabetes
Mesh:
Year: 2020 PMID: 32098897 PMCID: PMC7206923 DOI: 10.1136/bmjdrc-2019-001027
Source DB: PubMed Journal: BMJ Open Diabetes Res Care ISSN: 2052-4897
Characteristics of patients at the beginning of hospitalization
| Radio calisthenics (−) | Radio calisthenics (+) | P value | |
| Total number | 27 | 15 | – |
| Male | 13 (48.1) | 11 (73.3) | 0.11 |
| Age (years) | 65.8±12.6 | 62.9±14.5 | 0.50 |
| Weight (kg) | 64.1±16.3 | 70.8±19.4 | 0.24 |
| Body mass index (kg/m2) | 24.6±4.8 | 26.4±7.9 | 0.37 |
| Diabetes duration (years) | 14.5±9.0 | 12.2±8.5 | 0.44 |
| HbA1c (%) | 9.3±1.8 | 10.2±1.2 | 0.10 |
| HbA1c (mmol/mol) | 77.8±19.4 | 87.8±13.1 | 0.10 |
| FBS (mg/dL) | 167.7±51.5 | 156.3±32.3 | 0.44 |
| C-peptide (nmol/L) | 1.4±0.8 | 1.7±1.4 | 0.29 |
| Creatinine (mg/dL) | 0.73±0.2 | 0.77±0.2 | 0.63 |
| eGFR (mL/min/1.73 m²) | 77.8±23.5 | 80.5±27.2 | 0.74 |
| SMI (kg/m2) | 6.8±1.1 | 7.1±1.4 | 0.92 |
| Weight-adjusted SMI | 0.587±0.080 | 0.572±0.096 | 0.61 |
| Lean body mass (kg) | 23.3±5.3 | 25.2±6.8 | 0.32 |
| Right arm (kg) | 2.3±0.6 | 2.4±0.9 | 0.51 |
| Left arm (kg) | 2.2±0.6 | 2.4±0.9 | 0.40 |
| Trunk (kg) | 19.4±4.1 | 20.6±5.4 | 0.42 |
| Right leg (kg) | 6.6±1.6 | 7.3±2.1 | 0.26 |
| Left leg (kg) | 6.6±1.6 | 7.3±2.0 | 0.20 |
| Body fat mass (kg) | 20.4±9.9 | 23.7±13.3 | 0.38 |
| Drinking habits | 13 (48.1) | 2 (13.3) | 0.96 |
| Smoking states | 0.96 | ||
| Ex-smoker | 9 (33.3) | 6 (40) | |
| Current smoker | 7 (25.9) | 2 (13.3) | |
| Exercise habits | 5 (18.5) | 2 (13.3) | 0.65 |
| Insulin treatments | 8 (29.6) | 4 (26.7) | 0.35 |
| Retinopathy (NDR/SDR/PDR) | 19 (70.4)/5 (18.5)/3 (11.1) | 8 (53.3)/3 (20.0)/4 (13.7) | 0.20 |
| Nephropathy (normo/micro/macroalbuminuria) | 12 (44.4)/12 (44.4)/3 (11.1) | 10 (66.7)/2 (13.3)/3 (20) | 0.12 |
| Neuropathy | 12 (44.4)/13 (48.1) | 6 (40)/9 (60) | 0.62 |
Data are expressed as n (%) or mean±SD. Weight-adjusted SMI was defined as dividing skeletal muscle mass by the body weight. P values by Welch’s t-test for continuous variables and χ2 test for categorical variables.
eGFR, estimated glomerular filtration rate; FBS, fasting blood sugar; NDR, no diabetic retinopathy; PDR, proliferative diabetic retinopathy; SDR, simple diabetic retinopathy; SMI, skeletal muscle mass index.
Figure 1Change of SMI between (A) non-radio calisthenics exercisers and (B) radio calisthenics exercisers and during the hospitalization. SMI, skeletal muscle mass index.
Characteristics of patients at the beginning and end of hospitalization
| Radio calisthenics (−) | Radio calisthenics (+) | ||||||||
| Beginning | End | Change | P value* | Beginning | End | Change | P value* | P value† | |
| Weight (kg) | 64.1±16.3 | 62.4±15.2 | −1.66±0.40 | <0.001 | 70.8±19.4 | 69.2±18.0 | −1.55±0.53 | 0.030 | 0.861 |
| Body mass index (kg/m2) | 24.6±4.8 | 24.1±4.5 | −0.62±0.13 | <0.001 | 26.4±7.9 | 25.8±7.5 | −0.56±0.18 | 0.021 | 0.789 |
| SMI (kg/m2) | 6.8±1.1 | 6.5±1.2 | −0.27±0.06 | <0.001 | 7.1±1.4 | 7.1±1.3 | −0.01±0.09 | 0.914 | 0.016 |
| Weight-adjusted SMI | 0.37±0.05 | 0.37±0.05 | 0.00±0.01 | 0.708 | 0.36±0.06 | 0.37±0.06 | 0.01±0.01 | <0.001 | 0.003 |
| Lean body mass (kg) | 23.3±5.3 | 22.7±5.2 | −0.58±0.15 | <0.001 | 25.2±6.8 | 25.4±6.6 | −0.54±0.52 | 0.532 | 0.210 |
| Right arm (kg) | 2.3±0.6 | 2.2±0.6 | −0.09±0.02 | <0.001 | 2.4±0.9 | 2.5±0.8 | 0.04±0.03 | 0.316 | 0.003 |
| Left arm (kg) | 2.2±0.6 | 2.2±0.6 | −0.08±0.02 | <0.001 | 2.4±0.9 | 2.5±0.9 | 0.06±0.03 | 0.122 | 0.001 |
| Trunk (kg) | 19.4±4.1 | 19.0±4.1 | −0.43±0.12 | <0.001 | 20.6±5.4 | 20.9±5.3 | 0.28±0.16 | 0.170 | 0.001 |
| Right leg (kg) | 6.6±1.6 | 6.4±1.8 | −0.22±0.07 | 0.003 | 7.3±2.1 | 7.2±2.0 | −0.05±0.09 | 0.591 | 0.136 |
| Left leg (kg) | 6.6±1.6 | 6.2±1.8 | −0.32±0.13 | 0.040 | 7.3±2.0 | 7.2±2.0 | −0.07±0.17 | 0.426 | 0.250 |
| Body fat mass (kg) | 20.4±9.9 | 20.1±1.8 | −0.30±0.24 | 0.282 | 23.7±13.3 | 22.7±13.3 | −1.01±0.32 | <0.001 | 0.039 |
Data are mean±SD. Change was defined as the difference of SMI between the beginning and end of the hospitalization.
*P values are evaluated by paired t-test.
†P values are evaluated by Mann-Whitney U test.
SMI, skeletal muscle mass index.